AHSCX
Price
$12.15
Change
-$0.19 (-1.54%)
Updated
Feb 21 closing price
Net Assets
79.85M
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

AHSCX vs JNGLX

Header iconAHSCX vs JNGLX Comparison
Open Charts AHSCX vs JNGLXBanner chart's image
Alger Health Sciences C
Price$12.15
Change-$0.19 (-1.54%)
VolumeN/A
Net Assets79.85M
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
AHSCX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AHSCX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AHSCX is a StrongBuy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. AHSCX (79.9M). JNGLX pays higher dividends than AHSCX: JNGLX (0.12) vs AHSCX (0.00). AHSCX was incepted earlier than JNGLX: AHSCX (23 years) vs JNGLX (26 years). AHSCX is a more actively managed with annual turnover of: 305.60 vs. JNGLX (34.00). AHSCX has a lower initial minimum investment than JNGLX: AHSCX (1000) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. AHSCX (-9.73). JNGLX return over 5 years is better than : 17.54 vs. AHSCX (-43.80).
AHSCXJNGLXAHSCX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years26 years-
Gain YTD-4.9305.421-91%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets79.9M5B2%
Annual Yield % from dividends0.000.12-
Returns for 1 year-9.73-3.67265%
Returns for 3 years-10.8615.97-68%
Returns for 5 years-43.8017.54-250%
Returns for 10 years-38.9429.25-133%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P